Versigent PLC (VGNT)
| Market Cap | 3.07B |
| Revenue (ttm) | 9.24B +4.7% |
| Net Income | 522.00M +23.4% |
| EPS | 7.37 |
| Shares Out | 70.84M |
| PE Ratio | 5.89 |
| Forward PE | 6.21 |
| Dividend | $0.52 (1.20%) |
| Ex-Dividend Date | Sep 4, 2026 |
| Volume | 456,972 |
| Open | 44.14 |
| Previous Close | 43.87 |
| Day's Range | 42.78 - 44.14 |
| 52-Week Range | 26.34 - 50.89 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 56.78 (+30.86%) |
| Earnings Date | Nov 4, 2026 |
About VGNT
Versigent PLC designs, manufactures, and distributes low- and high-voltage power electrical architectures. The company offers signal and data connectivity solutions, power distribution systems, high-voltage electrical distribution systems, and EV charging solutions. It serves automotive, commercial vehicle, energy and grid, and other industries. The company was founded in 2026 and is based in Schaffhausen, Switzerland.
Financial Performance
In 2025, Versigent's revenue was $8.82 billion, an increase of 6.13% compared to the previous year's $8.31 billion. Earnings were $528.00 million, an increase of 29.41%.
Financial StatementsAnalyst Summary
According to 10 analysts, the average rating for VGNT stock is "Strong Buy." The 12-month stock price target is $56.78, which is an increase of 30.86% from the latest price.
News
Versigent price target raised to $53 from $52 at RBC Capital
RBC Capital raised the firm’s price target on Versigent (VGNT) to $53 from $52 and keeps an Outperform rating on the shares as part of a broader research note previewing…
Versigent price target lowered to $58 from $59 at Goldman Sachs
Goldman Sachs analyst Mark Delaney lowered the firm’s price target on Versigent (VGNT) to $58 from $59 and keeps a Buy rating on the shares as part of a broader…
Versigent Announces Third Quarter 2026 Earnings Call Details
SCHAFFHAUSEN, Switzerland--(BUSINESS WIRE)--Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low- and high-voltage electrical architectures, today announced it will release...
Versigent price target raised to $54 from $50 at Argus
Argus analyst Bill Selesky raised the firm’s price target on Versigent (VGNT) to $54 from $50 and keeps a Buy rating on the shares after its Q2 earnings beat last…
Versigent price target raised to $65 from $60 at Evercore ISI
Evercore ISI analyst Chris McNally raised the firm’s price target on Versigent (VGNT) to $65 from $60 and keeps an Outperform rating on the shares.
Versigent downgraded to Equal-Weight from Outperform at Fox Advisors
Fox Advisors analyst Steven Fox downgraded Versigent (VGNT) to Equal-Weight from Outperform, citing both the stock’s recent outperformance and management approaching its second half outlook “from a so...
Versigent price target raised to $58 from $49 at TD Cowen
TD Cowen analyst Itay Michaeli raised the firm’s price target on Versigent (VGNT) to $58 from $49 and keeps a Buy rating on the shares. The firm said its solid…
Versigent price target raised to $54 from $50 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Versigent (VGNT) to $54 from $50 and keeps a Buy rating on the shares.
Versigent price target raised to $59 from $48 at Goldman Sachs
Goldman Sachs raised the firm’s price target on Versigent (VGNT) to $59 from $48 and keeps a Buy rating on the shares.
Versigent upgraded to Outperform from Sector Perform at RBC Capital
RBC Capital analyst Tom Narayan upgraded Versigent (VGNT) to Outperform from Sector Perform with a price target of $52, up from $41. The company, post spin, is showing the “strength…
Versigent Earnings Call Transcript: Q2 2026
Q2 saw 11% net sales growth and 25% adjusted EBITDA growth, with strong performance in the Americas and Asia Pacific offsetting EMEA softness. 2026 guidance was raised for net sales but EBITDA and cash flow guidance were reaffirmed, reflecting copper and FX impacts. Dividend was initiated and bookings reached $2.8 billion.
Versigent Earnings release: Q2 2026
Versigent released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
Versigent Slides: Q2 2026
Versigent has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 4, 2026.
Versigent Quarterly report: Q2 2026
Versigent has published its Q2 2026 quarterly earnings report on August 4, 2026.
Versigent raises 2026 revenue view to $9.4B-$9.6B from $9.1B-$9.4B
2026 revenue consensus $9.31B. Backs 2026 adjusted EBITDA view $950M-$1.03B.
Versigent reports Q2 adjusted EPS $1.92, consensus $1.44
Reports Q2 revenue $2.44B, consensus $2.33B. “Versigent’s (VGNT) solid second-quarter results demonstrate our continued ability to unlock greater value, even in a dynamic environment,” said CEO Joseph...
Versigent Reports Second Quarter 2026 Results
SCHAFFHAUSEN, Switzerland--(BUSINESS WIRE)--Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low‑ and high‑voltage electrical architectures, today reported results for its ...
Versigent initiated with a Buy at Argus
Argus initiated coverage of Versigent (VGNT) with a Buy rating and $50 price target Versigent is a high-quality industrial technology company with significant margin expansion potential, supported by ...
Versigent initiated with a Buy at Goldman Sachs
Goldman Sachs initiated coverage of Versigent (VGNT) with a Buy rating and $48 price target implying 20% upside. Versigent is a leading provider of low and high voltage electrical architectures…
Versigent Announces Second Quarter 2026 Earnings Call
SCHAFFHAUSEN, Switzerland--(BUSINESS WIRE)--Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low‑ and high‑voltage electrical architectures, today announced that it will re...
Versigent price target raised to $41 from $34 at RBC Capital
RBC Capital raised the firm’s price target on Versigent (VGNT) to $41 from $34 and keeps a Sector Perform rating on the shares as part of a broader research note…
Versigent price target lowered to $55 from $58 at UBS
UBS lowered the firm’s price target on Versigent (VGNT) to $55 from $58 and keeps a Buy rating on the shares.
Versigent upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Edison Yu upgraded Versigent (VGNT) to Buy from Hold with a $50 price target
Versigent price target raised to $58 from $49 at UBS
UBS raised the firm’s price target on Versigent (VGNT) to $58 from $49 and keeps a Buy rating on the shares. Despite shares rising about 75% since the April 1…
Versigent Transcript: UBS Auto and Auto Tech Conference 2026
Production and revenue growth are outpacing the market, driven by strong APAC performance and focus on complex, high-value programs. Margin expansion is expected through automation, productivity, and commodity management, while adjacent markets and disciplined capital allocation offer future upside.